FSA Advisors Inc. Makes New Investment in Merck & Co., Inc. $MRK

robot
Abstract generation in progress

FSA Advisors Inc. recently acquired a new position in Merck & Co., Inc. (NYSE:MRK), purchasing 11,280 shares valued at approximately $1.187 million in the fourth quarter. This comes as Merck reported strong Q1 results, surpassing revenue and adjusted EPS expectations and setting optimistic FY2026 guidance, driven by growth in Keytruda and recent regulatory approvals. Despite mixed sentiment from insider selling and analyst target adjustments, the company maintains a “Moderate Buy” consensus rating.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin